Navigation Links
A Drop of Blood May Help Assess Cancer Therapy
Date:4/13/2009

Technique could one day quickly detect if treatment is working, study suggests

MONDAY, April 13 (HealthDay News) -- A specialized technique that can detect subtle changes in cancer cells contained in a drop of blood or a tiny piece of tissue may one day be used by doctors to better assess how cancers are responding to treatment, say U.S. researchers.

"Currently, we don't know what's going on in a patient's actual tumor cells when a treatment is given. The standard way we measure if a treatment is working is to wait several weeks to see if the tumor mass shrinks. It would really be a leap forward if we could detect what is happening at the cellular level," lead author Dr. Alice Fan, a clinical instructor in the oncology division at the Stanford University School of Medicine in California, said in a school news release.

"This technology allows us to analyze cancer-associated proteins on a very small scale," senior study author Dr. Dean Felsher, an associate professor of medicine and of pathology, said in the news release. "Not only can we detect picogram levels -- one-trillionth of a gram -- of protein, but we can also see very subtle changes in the ways the protein is modified."

Variations in the way a protein is modified can affect how it functions in tumor progression. Cancer cells can dodge common therapies by changing their levels of protein expression and degrees of modification, according to background information in the news release.

The ability to continuously analyze small samples from cancer patients undergoing treatment may help doctors identify "rogue" cells before they can create a more treatment-resistant tumor. This technology could also help identify patients with cancers that are resistant to standard treatments.

Tests showed the technique was effective in samples of blood cancers, and the researchers hope it will also help track solid tumors. The Stanford team collaborated with researchers from Cell Biosciences, which makes the machine used in the study.

The study is in the April 12 online issue of the journal Nature Medicine.

More information

The U.S. National Cancer Institute has more information about cancer.



-- Robert Preidt



SOURCE: Stanford University, news release, April 12, 2009


'/>"/>
Copyright©2009 ScoutNews,LLC.
All rights reserved  

Related medicine news :

1. Cord Blood America Announces First Storage Sale in Germany; Commitment to Expansion
2. Blood tests reveal tobacco smoke residues in non-smoking New Yorkers
3. Growth factor TGF-B helps maintain health of retinal blood vessels
4. Global Med Technologies(R), Inc. Licenses Its Leading European Blood and Laboratory Solutions to Homburg, Germany Clinic Blood Center
5. CVS Caremark Study Documents Changes in Prescription Drug Use to Treat High Blood Pressure, High Cholesterol and Diabetes in Children and Adolescents
6. More U.S. Kids Taking Diabetes, Blood Pressure Drugs
7. Stem cell therapy grows new blood vessels
8. Cord Blood Announces $1.75 Million Reduction in Long Term Debt
9. Arthritis Trial Leads to Potential Cure for High Blood Pressure
10. World-first high blood pressure treatment trialled in Melbourne
11. Haemonetics Bolsters Blood Bank Information Management Portfolio With Acquisition of Altivation Software
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
A Drop of Blood May Help Assess Cancer Therapy
(Date:12/7/2016)... ... December 07, 2016 , ... Augustine ... services to families and business owners in the greater Dallas metropolitan area, is ... Dallas Fallen Officer Foundation. , Established in 2009 by active police professionals in ...
(Date:12/7/2016)... (PRWEB) , ... December 07, 2016 , ... Sharon Kleyne, ... Global Climate Change and Your Health on Voice of America, declared on her radio ... call attention to the fact that when these bullies attack leaders in corporate America, ...
(Date:12/7/2016)... ... 07, 2016 , ... 1105 Media’s Live From program has ... Awards competition. Live From won in the Use of Social Media category. The ... projects undertaken by the media industry’s most innovative marketing professionals. , ...
(Date:12/7/2016)... ... 2016 , ... Maureen McLaughlin, LA.c., a certified acupuncturist, is ... Connecticut (RMACT). McLaughlin brings nearly 20 years of experience with fertility patients to ... their family building goals. Acupuncture helps fertility patients by supporting the ...
(Date:12/7/2016)... Va. (Dec. 3, 2016) , ... (PRWEB) December ... ... nation’s only patient advocacy nonprofit for individuals impacted by cerebral cavernous angiomas, was ... in New Mexico with a patient engagement program. New Mexico has more people ...
Breaking Medicine News(10 mins):
(Date:12/7/2016)...   Arena Pharmaceuticals, Inc. (NASDAQ: ... in the ralinepag phase 2 trial.  Ralinepag is an ... for the treatment of pulmonary arterial hypertension (PAH). The ... "This marks an important step in the development ... on our pipeline," said Amit Munshi , Arena,s ...
(Date:12/7/2016)... Conn. , Dec. 7, 2016 According to ... in more than one-third (38%) of patients with non-small cell ... epidermal growth factor receptor (EGFR) genetic mutation status. The findings ... ( LBA ID #6067 #P3.02b ) at the ... Vienna, Austria . The survey results revealed ...
(Date:12/7/2016)... LONDON , Dec. 7,2016  Based ... drug delivery industry, Frost & Sullivan recognizes ... Frost & Sullivan Award for Enabling Technology ... plug the loopholes in traditional drug delivery ... and liquid microneedle-based drug delivery technologies, Memspatch ...
Breaking Medicine Technology: